GVR Report cover Label-free Array Systems Market Size, Share & Trends Report

Label-free Array Systems Market Size, Share & Trends Analysis Report By Type (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular Dielectric Spectroscopy), By Application, By End-user, By Region, And Segment Forecasts, 2023 To 2030

  • Report ID: GVR453991
  • Number of Pages: 0
  • Format: Electronic (PDF)

Label-free array systems are analytical technologies that are used to detect and quantify biomolecules in complex samples without the use of fluorescent or radioactive labels. These systems rely on the principle of Surface Plasmon resonance (SPR) which allows detecting changes in the reflected light and quantifying the binding of biomolecules to the surface of the array. One of the main advantages of label-free array systems is that they do not require the use of hazardous or expensive labeling agents, making them a safer and more cost-effective alternative to traditional labeling methods. Additionally, because they do not rely on fluorescence or radioactivity, label-free array systems can be used to study biomolecule interactions in real time, providing dynamic and quantitative information about the binding kinetics and affinity of the interacting molecules.

In recent years, a number of companies have entered the market for label-free array systems, for instance, in November 2018, Agilent Technologies that has acquired ACEA Biosciences, a company that develops and manufactures label-free array systems for the detection and analysis of biomolecules. This acquisition was likely made in order to expand Agilent's portfolio of products and services in the label-free array systems market. This highlights the growing demand for label-free detection methods in the field of biological and biomedical research.

The label-free array systems market is driven by the increasing demand for personalized medicine, as well as a variety of other factors such as the prevalence of chronic diseases, increased research activities in biomedical science, the need for high-throughput screening, and the demand for cost-effective and efficient systems. Additionally, the focus on drug delivery efficiency, government funding for research activities and the emergence of new technologies such as nanotechnology are also contributing to the growth of the market. Companies such as Bruker are at the forefront of these developments, in June 2018 they launched new systems such as the Sierra SPR-32 system, which is equipped with R3 software that provides high sensitivity and the highest SPR throughput. This software increases the instrument's precision and productivity, and the label-free strategies will help accelerate the process of taking chemical entities to clinical trials.

The market is segmented based on type, application, end-user, and region. The type segment is divided into surface plasmon resonance, bio-layer interferometry, and cellular dielectric spectroscopy. The application segment is divided into drug discovery, protein interface analysis, antibody characterization, and others. The end-user segment is further segmented into pharmaceutical and biotechnology companies, academic and research institute, contract research organizations, and others

The label-free array systems market is expected to grow significantly in the coming years, driven by increasing demand from North America, Europe, and Asia Pacific. The U.S. and Canada, the UK, Germany, France, Japan, China, are India are the major contributors to the market. ForteBio is a leading provider of label-free array systems, such as the Octet Red system, which is a label-free, real-time biosensor used to study protein-protein interactions, protein-ligand interactions, and protein stability. The system is widely used in pharmaceutical and biotechnology research to aid in the discovery and development of new drugs and is marketed and sold by Pall ForteBio in the United States.

                                   Label-free Array Systems Market Segmentation

Segments

Details

Type

  • Surface Plasmon Resonance
  • Bio-layer Interferometry
  • Cellular Dielectric Spectroscopy
  • Others

Application

  • Drug Discovery
  • Protein Interface Analysis
  • Antibody Characterization
  • Others

End user

  • Pharmaceutical and Biotechnology Companies,
  • Academic and Research Institute
  • Contract Research Organization
  • Others

Region

  • North America (U.S., Canada),
  • Europe (UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway)
  • Asia Pacific (Japan, China, India, Australia, Thailand, South Korea)
  • Latin America (Brazil, Mexico, Argentina),
  • Middle East & Africa (Saudi Africa, South Arabia, UAE, Kuwait)

 

Label-free array systems have become increasingly popular and are used by a wide range of companies, from small startups to large multinational corporations. Prominent companies operating in the label-free array systems market include Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Sartorius AG. These companies are engaged in the development, manufacturing, and marketing of label-free array systems and their accessories to meet the requirements of various industries.

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon